Mylan NV (NASDAQ:MYL)

39.38
Delayed Data
As of May 25
 +0.05 / +0.13%
Today’s Change
29.39
Today|||52-Week Range
47.82
-6.93%
Year-to-Date

Today’s Trading

Previous close39.33
Today’s open39.37
Day’s range39.19 - 39.89
Volume2,235,264
Average volume (3 months)4,734,161
Market cap$19.7B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+17.63%
Earnings growth (next 5 years)+6.30%
Revenue growth (last year)+7.06%
P/E ratio29.2
Price/Sales1.91
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+4.21+4.77%
PRGOPerrigo Company PLC+0.13+0.17%
JAZZJazz Pharmaceuticals...+1.44+0.88%
ALNYAlnylam Pharmaceutic...+1.01+1.02%
Data as of 4:02pm ET, 05/25/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)$1.24
Annual revenue (last year)$11.9B
Annual profit (last year)$696.0M
Net profit margin5.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Heather M. Bresch
President &
Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts